Abnormal fat accumulation in the liver is a primary feature, and AhR activation can induce lipid deposition, potentially directly impacting the pathogenesis of NAFLD (Podechard et al., 2009). This evidence concerns the gene AHR and metabolic dysfunction-associated steatotic liver disease.